Key result
A 75-year-old woman with afebrile multi-valve infective endocarditis caused by Lactococcus garvieae was successfully treated with cardiac surgery and ceftriaxone after teicoplanin failure.
Case Report (n=1)
Lactococcus garvieae can cause afebrile multi-valve infective endocarditis in patients with prosthetic valves, which may require cardiac surgery and targeted antibiotic therapy for successful treatment.
L. garvieae may cause multi-valve prosthetic endocarditis; leaves open questions on its virulence and optimal therapy.
Lactococcus garvieae is considered to be a rare pathogen with low virulence in humans. We herein experienced an unusual case of multi-valve infective endocarditis caused by L. garvieae in an elderly woman who had undergone bioprosthetic mitral valve replacement due to severe mitral stenosis with rheumatic etiology. The patient was successfully treated with cardiac surgery after teicoplanin antimicrobial therapy failure followed by ceftriaxone treatment. L. garvieae was confirmed as the pathogen through 16S rRNA sequencing. To the best of our knowledge, this is the first case to indicate an effective treatment for infective endocarditis caused by L. garvieae in the Republic of Korea.
No takes yet. Share an insight, caveat, or question.
Suh et al. (2016) conducted a case report in Infective endocarditis caused by Lactococcus garvieae (n=1). Cardiac surgery and ceftriaxone was evaluated on Clinical cure and eradication of infection. A 75-year-old woman with afebrile multi-valve infective endocarditis caused by Lactococcus garvieae was successfully treated with cardiac surgery and ceftriaxone after teicoplanin failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: